Stay updated on Surufatinib & Toripalimab in Advanced Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Surufatinib & Toripalimab in Advanced Solid Tumors Clinical Trial page.

Latest updates to the Surufatinib & Toripalimab in Advanced Solid Tumors Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe site banner has been updated to Revision: v3.4.2, replacing the previous government funding notice.SummaryDifference0.5%

- Check21 days agoChange DetectedA site-wide government-funding lapse notice was added. The page revision was updated from v3.4.0 to v3.4.1.SummaryDifference0.5%

- Check28 days agoChange DetectedUI/metadata updates include a new 'Show glossary' toggle and revised QC labels, plus a release note 'Revision: v3.4.0'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision: v3.3.4 has replaced v3.3.3. This appears to be a backend version update with no visible changes to study details on the page.SummaryDifference0.1%

- Check63 days agoChange DetectedThe Locations section now lists Beijing Municipality and Shanghai Municipality under Locations, and the revision version updated to v3.3.3.SummaryDifference0.3%

- Check92 days agoChange DetectedThe Publications section now states that publications are automatically filled from PubMed, a public database, and the revision note updates the page version from v3.2.0 to v3.3.2.SummaryDifference0.1%

Stay in the know with updates to Surufatinib & Toripalimab in Advanced Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Surufatinib & Toripalimab in Advanced Solid Tumors Clinical Trial page.